Bacterial toxin activation and deployment: Context-dependent links to host immune remodeling

Many bacterial toxins are produced in latent or structurally constrained forms and acquire functional competence or productive access to host targets through distinct activation and deployment processes. This review distinguishes protein-level activation – including proteolytic maturation, reductive subunit release, metabolite-triggered autoprocessing, and host-factor-dependent catalytic activation – from receptor-mediated uptake, intracellular trafficking and translocation, vesicle-mediated delivery, and bacterial or phage-associated control of toxin expression and release. Across representative systems, these processes govern effector competence, availability, and localization and are associated with three broad immune outcomes: disruption of inflammatory signaling and cytokine networks, impairment of humoral defenses, and cell injury or regulated cell death. Their immune effects are often indirect and vary with host niche, cell type, receptor repertoire, trafficking route, and exposure timing. Distinguishing direct, effector-mediated, injury-mediated, availability-mediated, and unresolved relationships clarifies the boundaries of toxin activation and identifies priorities for in vivo validation and anti-virulence intervention.